Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program
Authors
Keywords
Advanced breast cancer, Circulating tumor cells (CTC), DETECT study program, Endocrine responsiveness score, HER2-phenotype of CTC, Targeted therapy
Journal
ARCHIVES OF GYNECOLOGY AND OBSTETRICS
Volume 293, Issue 2, Pages 271-281
Publisher
Springer Nature
Online
2015-09-09
DOI
10.1007/s00404-015-3879-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2014
- (2014) Volker Hanf et al. Breast Care
- Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500
- (2014) Jeffrey B. Smerage et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
- (2014) François-Clément Bidard et al. LANCET ONCOLOGY
- Decreased Androgen Receptor Expression Is Associated With Distant Metastases in Patients With Androgen Receptor–Expressing Triple-Negative Breast Carcinoma
- (2012) Lisa M. Sutton et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer
- (2012) S. T. Ligthart et al. ANNALS OF ONCOLOGY
- The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer
- (2012) Markus Wallwiener et al. BREAST CANCER RESEARCH AND TREATMENT
- Meta-Analysis of the Prognostic Value of Circulating Tumor Cells in Breast Cancer
- (2012) L. Zhang et al. CLINICAL CANCER RESEARCH
- High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients
- (2011) J.- Y. Pierga et al. ANNALS OF ONCOLOGY
- Q-TWiST analysis of ixabepilone in combination with capecitabine on quality of life in patients with metastatic breast cancer
- (2011) Patricia K. Corey-Lisle et al. CANCER
- Quality-adjusted survival analysis of first-line treatment of hormone-receptor-positive HER2+ metastatic breast cancer with letrozole alone or in combination with lapatinib
- (2011) Beth Sherrill et al. CURRENT MEDICAL RESEARCH AND OPINION
- HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
- (2010) Tanja Fehm et al. BREAST CANCER RESEARCH AND TREATMENT
- PIK3CA Mutations May Be Discordant between Primary and Corresponding Metastatic Disease in Breast Cancer
- (2010) J. Dupont Jensen et al. CLINICAL CANCER RESEARCH
- Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?
- (2009) C. Simmons et al. ANNALS OF ONCOLOGY
- Association between gain-of-function mutations in PIK3CA and resistance to HER2-targeted agents in HER2-amplified breast cancer cell lines
- (2009) Y. Kataoka et al. ANNALS OF ONCOLOGY
- Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor α and its phosphorylation at serine 305
- (2009) Cinzia Giordano et al. BREAST CANCER RESEARCH AND TREATMENT
- Circulating Tumor Cells: A Useful Predictor of Treatment Efficacy in Metastatic Breast Cancer
- (2009) Minetta C. Liu et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating tumor cells in metastatic breast cancer
- (2008) Shaheenah Dawood et al. CANCER
- Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235
- (2008) P. J.A. Eichhorn et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now